We're Redefining VC Advisory. We work with entrepreneurs working to build the future - assisting with regulated fundraising advisory and placing VC investment
Don't miss out on the UKBAA Early-Stage Investment Summit, which is taking place on Thursday at KPMG, Manchester! Have you booked your spot yet? Find out more: https://t.co/onDOQ4d5HR
So good to bring angel investors and entrepreneurs into a room for a lunch in Manchester
We’re going to double down on Mini Ecosystem sessions like this - fantastic discussion and a great laugh!
Thrilled that @Acceleris is nominated for the @EIS_Association Impact Award! We have targeted much more than financial returns with our portfolio over the years and it is great for our team and clients to be recognised! Fingers crossed! https://t.co/27euTH8Mgz
We are pleased to announce that we have been nominated for the @EISAssociation Impact Award 2022.
Check out the full list of finalists below:
https://t.co/IvFloB9ijT
#VC#Investment#awards2022#EISA
Celebrate the outstanding achievements of angels, early stage VC’s and the innovators they back!
It is the last day to submit your nominations for the UKBAA Awards 2022!
Nominate by midnight on 13th May: https://t.co/LzbuAsULA7 #UKBAAAwards
This is a story about the power of networking.
Yesterday @kpmguk & VC advisory firm Acceleris announced a game-changing JV to transform early-stage fundraising – but the story of how they came together is remarkable.
The story begins with @jmboyers …
https://t.co/6UDVVE0muE
Very excited to announce that KPMG has signed an agreement with Acceleris to launch a Venture Capital fundraising and advisory business with a particular focus on businesses in the technology, life sciences and ESG-related sectors.
Find out more here: https://t.co/z1nQ24R2ZM
Celebrate the outstanding achievements of angels, early stage VC’s and the innovators they back! It’s time to start thinking about who you want recognised at @ukbangels Angel investment awards event!
Nominate by midnight on 13th May: https://t.co/OJVFXlRAY9
#UKBAAAwards
Congratulations to @BiVictriX for winning the “Investment deal of the year award” at the @Bionow awards. Very well deserved and we look forward to what 2022 holds for the team.
We are pleased to announce that BiVictriX Therapeutics has won the “Investment Deal of the Year Award”, Sponsored by QIAGEN at this year’s @Bionow awards. Thank you to @Acceleris Capital for the nomination and to Bionow for organising the awards.
.@Vertical_Future, which grows crops without soil has successfully completed a £21m Series-A fundraise from investors including the @Acceleris syndicate alongside new UHNW, HNW and family office investors: https://t.co/mUN5w6km25 via @AngelNews#investment#growth
We are delighted to announce our Founder and Chairman Norman Molyneux has joined the Infection Innovation Consortium Advisory Board. @iiconNW supports the discovery and development of innovative new products and treatments for infectious diseases.
https://t.co/EamRnsyKu3
What do we do? Well, we optimise the fundraising process so you can focus on growing your business. Our venture capital fundraising process involves:
• Investment readiness
• Deal documentation
• Investor matching
• Deal completion support
https://t.co/gWIdiCza40
Invest deal by deal in game-changing startups/scale-ups alongside leading VC investors....with no fees 😲
Across 20 years we have backed ESG, cleantech, biotech, Telecomms, software, and more, with a market leading track record of exits and value growth.
*Capital is at Risk*
Reviewing pitch deck after pitch deck can be overwhelming - we see thousands! We've created the following article as a bit of a cheat sheet for initial reviews - "The 5 Things Investors Forget When Reviewing An Opportunity"
https://t.co/7t0BesWEvg